These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. Reeve J; Davies UM; Hesp R; McNally E; Katz D BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738 [TBL] [Abstract][Full Text] [Related]
3. Osteoporosis: cause and management. Anderson DC Br Med J (Clin Res Ed); 1987 Apr; 294(6578):1032-3. PubMed ID: 3119006 [No Abstract] [Full Text] [Related]
6. Treatment of osteoporosis with sodium fluoride or parathyroid hormone. Riggs BL Am J Med; 1991 Nov; 91(5B):37S-41S. PubMed ID: 1750415 [No Abstract] [Full Text] [Related]
7. Treatment of osteoporosis with parathyroid hormone and teriparatide. Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037 [TBL] [Abstract][Full Text] [Related]
8. The effect of parathyroid hormone and teriparatide on fracture healing. Campbell EJ; Campbell GM; Hanley DA Expert Opin Biol Ther; 2015 Jan; 15(1):119-29. PubMed ID: 25363308 [TBL] [Abstract][Full Text] [Related]
9. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957 [TBL] [Abstract][Full Text] [Related]
10. Past and future of anabolic agents. Ringe JD Ann Med Interne (Paris); 2000 Oct; 151(6):482-9. PubMed ID: 11104928 [No Abstract] [Full Text] [Related]
11. Formation-stimulating regimens other than sodium fluoride. Riggs BL Am J Med; 1993 Nov; 95(5A):62S-68S. PubMed ID: 8256799 [TBL] [Abstract][Full Text] [Related]
12. [Male osteoporosis: current treatments and future options]. Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284 [TBL] [Abstract][Full Text] [Related]
13. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis. Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908 [TBL] [Abstract][Full Text] [Related]
14. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study. Adachi JD; Hanley DA; Lorraine JK; Yu M Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204 [TBL] [Abstract][Full Text] [Related]
16. Use of teriparatide in osteoporotic fracture patients. Collinge C; Favela J Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289 [TBL] [Abstract][Full Text] [Related]
17. [Parathyroid hormone for osteroporsis: why and who to treat?]. Ferrari S; Rizzoli R Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450 [TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis. Hodsman A; ; Papaioannou A; ; Ann Cranney ; CMAJ; 2006 Jul; 175(1):48. PubMed ID: 16818909 [No Abstract] [Full Text] [Related]
19. Water fluoridation and osteoporotic fracture. Hillier S; Inskip H; Coggon D; Cooper C Community Dent Health; 1996 Sep; 13 Suppl 2():63-8. PubMed ID: 8897754 [TBL] [Abstract][Full Text] [Related]
20. [Anabolic activity of parathyroid hormone: a new therapeutic perspective in primary osteoporosis]. Fiore CE; Tamburino G Ann Ital Med Int; 1987; 2(4):321-6. PubMed ID: 3079455 [No Abstract] [Full Text] [Related] [Next] [New Search]